Literature DB >> 20425009

The role of local steroid injection for nasal polyposis.

Marcelo B Antunes1, Samuel S Becker.   

Abstract

Sinonasal polyps affect a small but significant percentage of patients with chronic sinusitis. Treatments vary and range from oral and topical medical treatments to surgical removal. Corticosteroids typically have been regarded as the gold standard medical treatment for sinonasal polyps. Delivery of steroids is traditionally via oral or topical means. Over the years, otolaryngologists have also found that intrapolyp injection of corticosteroids is an effective means to treat some patients with sinonasal polyps. This article reviews the prevalence, pathophysiology, and medical treatment options for sinonasal polyps. Focused attention is paid to treatment with steroid injections, including a review of its associated risks and benefits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425009     DOI: 10.1007/s11882-010-0104-4

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  62 in total

1.  Effects of TNF-alpha on expression of ICAM-1 in human airway epithelial cells in vitro. Signaling pathways controlling surface and gene expression.

Authors:  T M Krunkosky; B M Fischer; L D Martin; N Jones; N J Akley; K B Adler
Journal:  Am J Respir Cell Mol Biol       Date:  2000-06       Impact factor: 6.914

2.  [Treatment of allergic rhinitis accompanied by eczema with hydrocortisone acetate injected into nasal mucous membrane].

Authors:  E SIDI; R TARDIF
Journal:  Sem Hop       Date:  1955-05-30

3.  The pathology of the nose and paranasal sinuses in relation to allergy; with comments on the local injection of cortisone.

Authors:  H SEMENOV
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1952 Mar-Apr

Review 4.  Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects.

Authors:  A Cave; P Arlett; E Lee
Journal:  Pharmacol Ther       Date:  1999-09       Impact factor: 12.310

Review 5.  The molecular biology of leukocyte chemoattractant receptors.

Authors:  P M Murphy
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.

Authors:  J R White; J M Lee; K Dede; C S Imburgia; A J Jurewicz; G Chan; J A Fornwald; D Dhanak; L T Christmann; M G Darcy; K L Widdowson; J J Foley; D B Schmidt; H M Sarau
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

7.  Safety of steroid injections in the treatment of nasofrontal recess obstruction.

Authors:  J M Dutton; R M Bumsted
Journal:  Am J Rhinol       Date:  2001 Nov-Dec

Review 8.  Pharmacological management of nasal polyposis.

Authors:  Claus Bachert; Jean-Baptiste Watelet; Philippe Gevaert; Paul Van Cauwenberge
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Cytokine gene expression in nasal polyps.

Authors:  C H Lee; C S Rhee; Y G Min
Journal:  Ann Otol Rhinol Laryngol       Date:  1998-08       Impact factor: 1.547

10.  A study of allergic factor in nasal polyp patients.

Authors:  C Bunnag; P Pacharee; P Vipulakom; C Siriyananda
Journal:  Ann Allergy       Date:  1983-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.